Curapath is a company headquartered in Spain. Brouky records 1 investor associated with the company.
Curapath is a global CDMO specializing in GMP manufacturing of polymer and lipid-based drug delivery systems, providing end-to-end services for preclinical, clinical, and commercial stages with a focus on non-viral gene delivery via nanoparticles.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.